OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users

Published 2010 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users
Authors
Keywords
-
Journal
NEUROGENETICS
Volume 12, Issue 1, Pages 79-82
Publisher
Springer Nature
Online
2010-08-01
DOI
10.1007/s10048-010-0254-5
References
View 2 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.